Patent ID: 11905274
Assignee: BEIJING TIDE PHARMACEUTICAL CO., LTD.
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 2:
3. The compound according to claim 1, or a pharmaceutically acceptable salt, ester, stereoisomer, polymorph, solvate, N-oxide, isotopically labeled compound, or prodrug thereof, wherein:
said rings A, B, C and D are each independently cyclopentyl, cyclohexyl, 5- to 7-membered monocyclic heterocyclic group, phenyl or 5- to 6-membered heteroaryl; and/or
R3 is selected from the group consisting of 5 to 14-membered heteroaryl, —C(═O)OR11, —C(═O)NR11—OH, —C(═O)NR11S(═O)yNR11R12, —C(═O)NR11S(═O)yR12, and —S(═O)yNR11C(═O)OR12; and/or
R4 is H; and/or
R10 is selected from the group consisting of H, C1-6 alkyl, C3-10 cyclic hydrocarbyl group, —OR11, —SR11, and —NR11R12.